Life sciences news
-
UCB announces positive data in myasthenia gravis with zilucoplan phase 3 study results
Friday February 4th 2022
Read more
-
Large UK study shows rapid EGFR testing with Idylla™ alongside NGS has potential to enhance lung cancer patient health outcomes
Tuesday January 25th 2022
Read more
-
Mithra announces positive top-line results from Donesta® Phase 3 studies in menopausal women
Friday January 14th 2022
Read more
-
Oxurion provides update on clinical pipeline progress
Friday January 7th 2022
Read more
-
VIB research at the basis of experimental gene therapy against dementia
Wednesday December 22nd 2021
Read more
-
UCB announces positive Phase 3 results for rozanolixizumab in generalized myasthenia gravis
Friday December 10th 2021
Read more
-
MRM Health announces first patient dosed with next generation live microbiome consortia therapeutic MH002 in Phase 1b/2a study in patients with Ulcerative Colitis
Wednesday December 8th 2021
Read more
-
Sequana Medical announces the completion of patient enrolment in POSEIDON, the North American pivotal alfapump® study
Tuesday December 7th 2021
Read more
-
Become a flanders.bio member
Your news here?
-
Sequana Medical announces positive interim results of SAHARA DESERT, the alfapump DSR® study in heart failure patients with persistent congestion
Tuesday December 7th 2021
Read more
-
S-Biomedic announces topline results of a successful clinical study in acne
Friday November 26th 2021
Read more
-
Galapagos completes patient recruitment for MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
Tuesday November 23rd 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
